Literature DB >> 25300669

Botulinum toxin: a novel treatment for pediatric cyclic esotropia.

Alistair Jones1, Saurabh Jain2.   

Abstract

Cyclic esotropia is a rare entity in which an esotropia presents in a regular 48-96 hour cycle, typically described as a 24-hour period of orthotropia followed by a 24-hour period of esotropia. The underlying mechanism of this phenomenon is unknown. Treatment usually involves surgical correction of the manifest strabismus. We report the case of a 3-year-old girl whose cyclic esotropia was broken following injection of botulinum toxin to both medial rectus muscles. She has remained constantly esophoric for 1 year.
Copyright © 2014 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25300669     DOI: 10.1016/j.jaapos.2014.07.155

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  3 in total

1.  Botulinum toxin for the treatment of cyclic esotropia in a child with Chiari type I malformation.

Authors:  Inae E Jang; John A Davis; K David Epley; Michelle T Cabrera
Journal:  J AAPOS       Date:  2020-04-07       Impact factor: 1.220

Review 2.  The best of the best: a review of select pediatric ophthalmology and strabismus case reports published in 2015.

Authors:  Pavlina S Kemp
Journal:  Digit J Ophthalmol       Date:  2016-11-14

3.  Cyclic esotropia with development of a high accommodative convergence to accommodation ratio after surgery for intermittent exotropia.

Authors:  Xi Wang; Bingjie Chen; Longqian Liu
Journal:  Int Ophthalmol       Date:  2016-09-15       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.